Omicron overpowers key COVID antibody treatments in early tests

Nature, Published online: 21 December 2021; doi:10.1038/d41586-021-03829-0

Nearly all of the monoclonal antibodies used to prevent severe disease fail to stand up to the new variant, laboratory assays show.